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The Calculation of the 97.5% Upper
Confidence Bound: Application to Clustered
Binary Data in a Binomial Non-Inferiority
Two-Sample Trial.
William F. McCarthy

Abstract

This paper will discuss the analysis of a cluster randomized binomial non-inferiority
two-sample trial. The determination of the intra-cluster correlation coefficient
(ICC) and its use in the calculation of the 97.5% upper confidence bound for
delta, the true difference in binomial proportions between the active control and
the experimental treatment groups, will be outlined.

As noted in the EMEA guideline on the choice of the non-inferiority margin (2005), “Many clinical
trials comparing an experimental treatment with an active control are designed as non-inferiority
trials. The term ‘non-inferiority’ is now well established, but if taken literally could be misleading.
The objective of a non-inferiority trial is sometimes stated as being to demonstrate that the
experimental treatment is not inferior to the active control. However, only a superiority trial can
demonstrate this. In fact, a non-inferiority trial aims to demonstrate that the experimental
treatment is not worse than the active control by more than a pre-specified, small amount. This
amount is known as the non-inferiority margin, or delta ( δ 0 ).”
It is common practice to adopt the 2.5% significance level for a non-inferiority test, since the test
is one-sided. Thus, we would consider the 97.5% upper confidence bound for δ , the true
difference in binomial proportions between the active control and the experimental treatment
groups.

Example

This paper will discuss the analysis of a cluster randomized binomial non-inferiority two-sample
trial. An earlier paper discussed the design and sample size requirements of a cluster randomized
binomial non-inferiority two-sample trial (McCarthy, 2008). A cluster will be defined as a private
practice whose elements are patients. Each cluster will be specific to a treatment assignment (i.e.,
either the experimental treatment or the active control). The goal was to have an equal allocation
of clusters between the two treatment assignments but an imbalance occurred: 17 clusters for the
experimental treatment and 12 for the active control → a total of 29 clusters. The size of each
cluster varied (from 6 to 35 patients; an average cluster size of 23.3). Lets assume the event of
interest is one that denotes patient harm (e.g., death).
Denote

π c as the event rate for the active control group and π t as the event rate for the

experimental treatment group.
Let

δ = πc −πt .

Let the non-inferiority margin be denoted as

δ0 .

The null hypothesis is H 0 : δ = δ 0 and is tested against a one-sided alternative hypothesis.
Since the occurrence of an event denotes patient harm rather than benefit, then

δ 0 < 0 and the

alternative hypothesis is H1 : δ > δ 0 or equivalently as H1 : π t < π c − δ 0 .

π c , the sample size is determined by the desired power at a specified value of
δ = δ1 . A common choice is δ1 = 0 or (equivalently π t = π c ). Let δ1 = 0 .

For any given

π c = 0.500.
The non-inferiority margin is assumed to be δ 0 = - 0.050, i.e., π t =0.550.

The active control group event rate is assumed to be

Thus, to demonstrate non-inferiority, the 97.5% upper confidence bound when clustering is
considered needs to be within the prescribed non-inferiority margin of - 0.050.
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Lets illustrate the result of each clusteri of the trial as

yi
. The numerator yi is the number of
ni

events in cluster i and the denominator ni is the size of clusteri.
For the experimental treatment arm we have:
yi = { 0 0 0 6 2 4 1 2 3 1 6 9 8 6 10 4 4}
ni = {30 22 19 30 30 30 30 30 30 30 30 30 22 22 32 31 20}
For the active control group we have:
yi = { 2 3 6 1 3 3 2 5 18 21 19 21}
ni = {16 11 35 10 9 11 6 12 25 25 23 24}

It should be noted that we could convert this analysis from one of “harm” (death) to one of
“benefit” (still alive) as follows (this is done to make the analysis compatible with standard
statistical software):

If the occurrence of a response denotes patient benefit rather than harm, then δ 0 > 0 and the
alternative hypothesis is H1 : δ < δ 0 or equivalently as H1 : π t > π c − δ 0 .

π c = 1- 0.500 = 0.500.
The non-inferiority margin is assumed to be δ 0 = + 0.050, i.e., π t =1 - 0.550 = 0.450.
The active control group event rate is assumed to be

Thus, to demonstrate non-inferiority, the 97.5% upper confidence bound when clustering is
considered needs to be within the prescribed non-inferiority margin (i.e., π t > π c − δ 0 ).
For the experimental treatment arm we have:
yi = {30 22 19 24 28 26 29 28 27 29 24 21 14 16 22 27 16}
ni = {30 22 19 30 30 30 30 30 30 30 30 30 22 22 32 31 20}
For the active control group we have:
yi = {14 8 29 9 6 8 4 7 7 4 4 3}
ni = {16 11 35 10 9 11 6 12 25 25 23 24}
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Steps of Analysis:

We use the data that represents “benefit”. We first analyze the data as if no clustering was
involved. We put the data in table form, as shown below. We will use StatXact 7 for our analysis.
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Using StatXact 7 we compute the unconditional test of non-inferiority using the difference of the
two binomial proportions. The results are below:

Thus, we have:

π c = 0.4976
π t = 0.8590
δ

= - 0.3614

se( π 2 − π 1 − δ 0 )= 0.03581
95% upper confidence bound = - 0.2861.

The results above assumed no clustering was involved. We get a difference of proportions of
δ = - 0.3614 and a se( π 2 − π 1 − δ 0 ) = 0.03581.
Next, we want to compute the 97.5% upper confidence bound for

δ

with clustering considered.
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In a talk presented by J M Bland to the RSS Medical Section and the RSS Liverpool Local Group,
12 NOV 2003, Bland stated “the magnitude of the effect of clustering is measured by the design
effect, Deff, given by the following: Deff = 1 + (n - 1)(ICC) where n is the number of observations in
a cluster and ICC is the intra-cluster correlation coefficient. The ICC is the correlation between
pairs of subjects chosen at random from the same cluster. It is usually quite small, 0.04 is a
typical figure. This was the median ICC reported in the review by Eldridge et al. (2004). If n=1,
cluster size one, in other words, no clustering, then Deff=1, otherwise Deff will exceed 1 (this
assumes a positive correlation between pairs of subjects).
We can use this in two ways. In design, if we estimate the required sample size ignoring
clustering, we must multiply it by the design effect to get the sample size required for the
clustered sample. Alternatively, we can say that if the sample size is estimated ignoring the
clustering, the clustered sample has the same power as for a simple sample of size equal to what
we get if we divide our sample size by the design effect.
In analysis, if we analyse the data as if there were no clusters, the variances of the estimates must
be multiplied by Deff, hence the standard error must be multiplied by the square root of Deff.
From this formula, we can see that clustering may have a large effect if the ICC is large or if the
cluster size is large. Only one of these conditions need be met. For example, if the ICC is 0.001, a
very small correlation, and the cluster size is 500, the design effect will be 1 + (500-1)x0.001 = 1.5
and we would need to increase the sample size by 50% to achieve the same power as an
unclustered trial.
In addition, we need to estimate variances both within and between clusters. If the number of
clusters is small, the between clusters variance will have few degrees of freedom and we will be
using the t distribution in inference rather than the Normal. This too will cost in terms of power.”
ICC ( ρ ) is the correlation between pairs of patients chosen at random from the same cluster.

σB

2

ρ=

σ B + σW
2

2

where σ B is the between cluster variability
2

where σ W is the within cluster variability
2

the size of the ICC is generally larger for smaller clusters
small cluster ∼ 0 to 0.3
(large ICC)
medium cluster ∼ 0 to 0.05

(medium ICC)

large cluster ∼ 0 to 0.001

(small ICC)

Thus, to account for clustering, we will analyze the data as if there were no clusters, compute the
ICC and the Deff, and finally we will multiply the standard error by the square root of the Deff.
Donner and Klar (2000) and Reed (2004) have also discussed the impact of ICC on analysis.
Ridout et al. (1999) evaluated 20 different methods for estimating the ICC with binary outcomes
and found that the kappa-type method originally proposed by Fleiss and Cuzick (1979) performed
best under a variety of conditions. Zou and Donner (2004) have written an IML SAS program for
estimating the ICC for binary outcomes using the Fleiss and Cuzick method.
Using the IML program of Zou and Donner –> see Appendix A, we compute the intra-cluster
correlation coefficient (ICC) for our data set (refer to page 2). The ICC = 0.32.
To get the SE when clustering is considered, we multiply the SE from StatXact by the

Deff .
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_

_

Deff = 1 + ( n -1)(ICC), where n is the average cluster size and ICC is the intra-cluster correlation
coefficient.

_

For this data set, n =23.3 and ICC=0.32.
Thus Deff = 1 + (23.3-1)(0.32) = 8.14.

Deff =

SE

(

8.14 = 2.85.

)

Deff = 0.03581(2.85) = 0.10206.

Thus, the 97.5% upper confidence bound when clustering is considered is:
- 0.3614 + 1.96 (0.10206) = - 0.1614.

not clustered
clustered

Upper Limit
- 0.2861
- 0.1614

Since the 97.5% upper confidence bound when clustering is considered is - 0.1614, and it is
comfortably within the prescribed non-inferiority margin of + 0.50, we can claim non-inferiority.
Also notice how the effect of clustering increased the se( π 2 − π 1 − δ 0 ), from 0.03581 (not
clustered) to 0.10206 (clustered). This in turn increased the upper limit from – 0.2861 to – 0.1614,
but not enough to be ≥ + 0.05 (our non-inferiority margin).

We can also compute the p-value for this one-sided test:
The standardized test statistic is

π 2 − π1 − δ 0
se(π 2 − π 1 − δ 0 )

=

0.4976 − 0.8590 − 0.050 −0.4114
=
= −4.03 .
0.10206
0.10206

This gives a p-value = 0.000028 which is less than the nominal 0.025. Thus, we can reject the null
hypothesis H 0 : δ = δ 0 . This allows us to claim non-inferiority.
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Appendix A.
*************************************************************************************;
* Zou and Donner (2004)Confidence interval estimation of the intraclass correlation *;
* coefficient for binary outcome data Biometrics Vol 60 (3) pp 807-811
*;
*
*;
*
EXAMPLE
*;
*
*;
*
***** Fleiss-Cuzick *****
*;
*
*;
*
Clusters 1-17 intervention group, clusters 18-29 control group
*;
*
Cluster denoted i, patient within cluster denoted j
*;
*
Binary outcome data: yij=1 if event, yij=0 if non-event
*;
*
yi is the number of events in cluster i
*;
*
ni is the total number of patients in cluster i
*;
*
*;
*
Modified by W.F. McCarthy 7/02/2008
*;
*************************************************************************************;

***** SAS IML codes *******;
proc iml;
start cubic(a, b, c, d);
l=.; u=.;
if (a = 0) then do;
if c**2 - 4*b*d > 0 then do;
l = (-c - sqrt(c**2 - 4*b*d))/(2*b);
u = (-c + sqrt(c**2 - 4*b*d))/(2*b);
end;
end;
else do;
a1 = b/a; a2=c/a; a3 = d/a;
r = a1*a2/6 - a3/2 - a1**3/27;
q = a2/3 - a1**2/9;
if q < 0 then do;
f= r/sqrt(-q**3);
if abs(f) <=1 then do;
*if f >1 then f = 1;
*if f <-1 then f =-1;
theta = arcos(f);
pi = 3.1415926;
k = 2*sqrt(-q)*cos(theta/3) -a1/3;
l = 2*sqrt(-q) * cos ( (theta+2*pi)/3 ) - a1/3;
u = 2*sqrt(-q) * cos ( (theta+4*pi)/3 ) - a1/3;
end;
end;
end;
return(l||u||k);
finish cubic;

start interval4ICC(alpha, data);
crit = probit( 1- alpha/2);
chi = crit**2;
yi = data[,1];
ni = data[,2];
bigN = sum(ni);
piest= sum(yi)/bigN;
piHat = piest;
index = piest * (1 - piest);
k = nrow(ni); * 29; *clusters;
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****** Fleiss-Cuzick **********;
rhoHat = 1 - sum ( yi#(ni-yi)/ni )/((bigN- k)* piest*(1-piest));

part1 = ((1/index - 6) * sum(1/ni))/(bigN - k)**2 + ((2 *bigN
+ 4 * k - k/index) * k)/(bigN * (bigN - k)**2);
part2 = sum(ni##2)/(bigN**2 * index)(3 * bigN - 2 * k) * (bigN - 2 * k) * sum(ni##2)/
(bigN**2* (bigN - k)**2) - (2 * bigN - k)/(bigN - k)**2;
part3 = (4-1/index)*(sum(ni##2) - bigN)/bigN**2;
vFC = (1 - rhoHat) * (part1 + part2*rhoHat + part3*rhoHat**2);
**
A2
B2
C2
D2

CUBIC ****;
= - part3;
= part3 - part2;
= part2 - part1;
= part1;

A22 =chi*A2;
B22 =chi*B2 - 1;
C22 =chi*C2 + 2* rhoHat;
D22 =chi*D2 - rhoHat**2;
solution2 = cubic(A22, B22, C22, D22);
lower = solution2[,1];
upper = solution2[,2];
print alpha piHat rhoHat lower upper;
finish interval4ICC;

*
*
*
*
*

Clusters 1-17 intervention group, clusters 18-29 control group;
cluster denoted i, patient within cluster denoted j;
Binary outcome data yij=1 if event, yij=0 if non-event;
yi is the number of events in cluster i;
ni is the total number of patients in cluster i;

yi = {0
0 0 6 2 4 1 2 3 1 6 9 8 6 10 4 4 2 3 6 1 3 3 2 5 18 21 19 21};
ni = {30 22 19 30 30 30 30 30 30 30 30 30 22 22 32 31 20 16 11 35 10 9 11 6 12 25 25 23 24};
yi = t(yi);
ni = t(ni);
print 'Example';
data =yi||ni;
run interval4ICC(0.05, data);
quit;

/* OUTPUT from SAS Program */
/* RHOHAT is the ICC */
/* HARM IS CONSIDERED, HOWEVER THE ICC FOR BENEFIT IS THE SAME */

Example
ALPHA
0.05

PIHAT
0.2518519

RHOHAT
0.315556

LOWER
0.1262249

UPPER
0.5592528
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